Overview
The IASLC Education Committee presents a one-hour live session focused on reviewing and discussing the most impactful topics presented at the 2025 Hot Topic: Unraveling Precancer and Early-Stage Lung Cancer Conference.
- Describe recent advances in the molecular and cellular mechanisms involved in early lung carcinogenesis.
- Summarize key preclinical and clinical developments in the management of early-stage lung cancer.
- Assess current basic and translational research on oncogenesis and disease biology, including emerging therapeutic strategies and ongoing clinical applications.
- Pan-Chyr Yang, MD, PhD – Molecular Mechanisms of Early Lung Cancer Progression: EGFR Mutations
- Daniel Shao-Weng Tan, PhD – Integrating Biology, Detection, Diagnostics, and Treatment for Early Lung Cancer: A Path Forward
- Charles Swanton, PhD – Advancing SCLC Research
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Association for the Study of Lung Cancer is accredited by the ACCME to provide continuing medical education for physicians.
The International Association for the Study of Lung Cancer designates the live format for this educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- Describe recent advances in the molecular and cellular mechanisms involved in early lung carcinogenesis.
- Summarize key preclinical and clinical developments in the management of early-stage lung cancer.
- Assess current basic and translational research on oncogenesis and disease biology, including emerging therapeutic strategies and ongoing clinical applications.
- Pan-Chyr Yang, MD, PhD – Molecular Mechanisms of Early Lung Cancer Progression: EGFR Mutations
- Daniel Shao-Weng Tan, PhD – Integrating Biology, Detection, Diagnostics, and Treatment for Early Lung Cancer: A Path Forward
- Charles Swanton, PhD – Advancing SCLC Research
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Association for the Study of Lung Cancer is accredited by the ACCME to provide continuing medical education for physicians.
The International Association for the Study of Lung Cancer designates the live format for this educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Share
Participants
Hidehito Horinouchi
MD, PhD
Assistant Chief of the Department of Thoracic Oncology
National Cancer Center Hospital
Charles Swanton
PhD
Deputy Clinical Director
The Francis Crick Institute
Pan-Chyr Yang
MD, PhD
Dean of the College of Medicine
National Taiwan University Hospital
Daniel Shao-Weng Tan
PhD
Senior Consultant Medical Oncologist, Division of Medical Oncology
National Cancer Centre Singapore